TY  - JOUR
AU  - Pérez-Valero, Ignacio
AU  - Pasquau, Juan
AU  - Rubio, Rafael
AU  - Rivero, Antonio
AU  - Santos, José
AU  - Sanz, Jesus
AU  - Mariño, Ana
AU  - Crespo, Manel
AU  - Hernández-Quero, Jose
AU  - Iribarren, José Antonio
AU  - Gutiérrez, Félix
AU  - Terrón, Alberto
AU  - Esteban, Herminia
AU  - Pérez-Molina, José Antonio
AU  - GESIDA 7011 Study Group members
PY  - 2018
DO  - 10.1093/jac/dky212
UR  - http://hdl.handle.net/10668/12586
T2  - The Journal of antimicrobial chemotherapy
AB  - Concerns have been voiced over the capacity of deintensification strategies to preserve neurocognitive function and prevent neurocognitive impairment. We present the 96 week results of a neurocognitive substudy nested within the SALT clinical trial: a...
LA  - en
KW  - Adult
KW  - Anti-HIV Agents
KW  - Atazanavir Sulfate
KW  - Female
KW  - HIV Infections
KW  - Humans
KW  - Lamivudine
KW  - Longitudinal Studies
KW  - Male
KW  - Middle Aged
KW  - Neurocognitive Disorders
KW  - Ritonavir
TI  - Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial.
TY  - research article
VL  - 73
ER  -